Resverlogix Corp clinical-stage biotechnology company... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| TPYYX | 8.17 | 0.09 | +1.11% |
| Touchstone Sands Capital Intl Gr Eq Y | |||
| IHORX | 19.29 | 0.17 | +0.89% |
| Hartford International Opportunities R3 | |||
| SAGWX | 5.27 | 0.04 | +0.76% |
| Touchstone Small Company A | |||
| RNPFX | 58.53 | 0.30 | +0.52% |
| American Funds New Perspective R5 | |||
| SBHVX | 12.28 | 0.06 | +0.49% |
| Segall Bryant & Hamill Sm Cp Val Ins | |||
A.I.dvisor tells us that RVXCF and TELIF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RVXCF and TELIF's prices will move in lockstep.
| Ticker / NAME | Correlation To RVXCF | 1D Price Change % | ||
|---|---|---|---|---|
| RVXCF | 100% | N/A | ||
| TELIF - RVXCF | 22% Poorly correlated | +2.73% | ||
| GRCE - RVXCF | 21% Poorly correlated | +2.45% | ||
| FULC - RVXCF | 20% Poorly correlated | +7.52% | ||
| NEUP - RVXCF | 20% Poorly correlated | +0.57% | ||
| SQZB - RVXCF | 20% Poorly correlated | N/A | ||
More | ||||